碳离子与光子放疗致局部晚期非小细胞肺癌急性放射性食管炎的相对生物学效应:基于NTCP模型
本研究基于倾向性评分匹配的165对局部晚期非小细胞肺癌患者,利用Lyman-Kutcher-Burman正常组织并发症概率模型评估碳离子放疗相对于光子放疗对急性放射性食管炎(≥2级)的相对生物学效应。碳离子组≥2级急性放射性食管炎发生率为6.7%,光子组为19.4%(P < .001)。由TD₅₀比值推导的碳离子相对生物学效应估计值为3.02。
要点
- 碳离子放疗组≥2级急性放射性食管炎发生率为6.7%,低于光子放疗组的19.4%(P < .001)。
- LKB NTCP模型拟合碳离子物理TD₅₀为23.37 Gy,光子物理TD₅₀为70.50 Gy。
- 基于TD₅₀比值估算碳离子对≥2级急性放射性食管炎的RBE值为3.02。
核心结论
- 基于LKB NTCP模型估算,碳离子放疗对≥2级急性放射性食管炎的RBE值为3.02。
研究设计与样本
- 主要终点为放疗期间或放疗后3个月内≥2级急性放射性食管炎(CTCAE v5.0)。
- 采用最大似然估计构建LKB NTCP模型,以3折交叉验证和ROC曲线下面积评估模型性能。
主要发现
- 碳离子组≥2级急性放射性食管炎发生率为6.7%,光子组为19.4%(P < .001)。
- 碳离子组LKB模型最佳拟合参数为m = 0.18、n = 0.15、TD₅₀ = 23.37 Gy(物理剂量)。
- 光子组LKB模型最佳拟合参数为m = 0.33、n = 0.14、TD₅₀ = 70.50 Gy(物理剂量)。
- 碳离子组和光子组平均AUC分别为0.81 ± 0.14和0.66 ± 0.17。
关键数值与推荐
- 碳离子放疗对≥2级急性放射性食管炎的RBE估计值为3.02,由光子组与碳离子组TD₅₀比值推导。
临床怎么用
- LKB NTCP模型可为碳离子放疗的相对生物学效应估计提供临床导向的框架。
- 研究提示碳离子放疗可能降低局部晚期非小细胞肺癌患者≥2级急性放射性食管炎风险。
局限性
- 需更大患者队列和外部验证以提高模型的泛化性和临床适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to evaluate the relative biological effectiveness (RBE) of carbon-ion radiation therapy (CIRT) versus photon radiation therapy for acute radiation-induced esophagitis (ARIE) in patients with locally advanced non-small cell lung cancer, based on TD₅₀ derived from normal tissue complication probability (NTCP) models. METHODS AND MATERIALS: A total of 165 propensity score-matched pairs of patients with locally advanced non-small cell lung cancer treated with CIRT or photon radiation therapy between January 2016 and December 2023 were analyzed. ARIE (grade ≥2, National Cancer Institute Common Terminology Criteria for Adverse Events v5.0) during or within 3 months postradiation therapy was the primary endpoint. The Lyman-Kutcher-Burman (LKB) NTCP model was developed using maximum-likelihood estimation. Model performance was assessed via 3-fold cross-validation and area under the receiver operating characteristic curve. The estimated RBE value was the TD₅₀ ratio between the photon radiation therapy and CIRT groups. RESULTS: Grade ≥2 ARIE was observed in 6.7% of patients treated with CIRT and 19.4% of those treated with photons (P < .001). Best fitted parameters of the LKB model were: m = 0.18, n = 0.15, and TD₅₀ = 23.37 Gy for CIRT (physical); and m = 0.33, n = 0.14, and TD₅₀ = 70.50 Gy for photon radiation therapy (physical). The corresponding mean area under the curves were 0.81 ± 0.14 and 0.66 ± 0.17, respectively. For CIRT, the RBE value derived from the LKB NTCP model was estimated to be 3.02 for grade ≥2 ARIE. CONCLUSIONS: LKB-based NTCP modeling offers a clinically oriented framework to estimate RBE value for CIRT. Larger patient cohorts and external validation are required to enhance the model's generalizability and clinical applicability.
引用
- Liu Y, Ma N, Li Y, et al. Relative Biological Effectiveness of Carbon Ion Versus Photon Radiation Therapy for Acute Radiation-Induced Esophagitis in Locally Advanced Non-small Cell Lung Cancer Derived From Normal Tissue Complication Probability Modeling. Adv Radiat Oncol. 2026. PMID: 41853485. doi:10.1016/j.adro.2026.102004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。